Ben Axler's Case For Shorting Danimer Scientific (DNMR)

Ben Axler, Founder & Chief Investment Officer at Spruce Point Capital Management, explains his concerns on Danimer Scientific including that the growth expansion story is likely to fail. He points out several corporate governance red flags involving past and current CEOs.

ON AIR
7:00 am
Market Overtime
replay

Get Market Minute

Daily insights for every investor

FOLLOW US

Ben Axler's Case For Shorting Danimer Scientific (DNMR)

Ben Axler, Founder & Chief Investment Officer at Spruce Point Capital Management, explains his concerns on Danimer Scientific including that the growth expansion story is likely to fail. He points out several corporate governance red flags involving past and current CEOs.

ON AIR
7:00 am
Market Overtime
replay

Get Market Minute

Daily insights for every investor

FOLLOW US